1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus

Lupus

Volumn 20, Issue 13, 2011, Pages 1411-1420

  Ouyang, X ^a   Dai, Y ^a   Wen, J L ^a   Wang, L X ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

1H NMR spectroscopy; metabolomics; pattern recognition; systemic lupus erythematosus

Indexed keywords

ALANINE; CHOLESTEROL; CITRIC ACID; CREATINE; CREATININE; FORMIC ACID; GLUTAMINE; GLYCEROL; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; HISTIDINE; ISOLEUCINE; LOW DENSITY LIPOPROTEIN; LYSINE; N ACETYL GLYCOPROTEIN; PHENYLALANINE; PYRUVIC ACID; TYROSINE; UNCLASSIFIED DRUG; VALINE; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; ORTHOGONAL PARTIAL LEAST SQUARES DISCRIMINANT ANALYSIS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS;

EID: 81555223869     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311418707     Document Type: Article

References (41)

1. Gerli R, Nocentini G, Alunno A, et al. Identification of regulatory T cells in systemic lupus erythematosus. Autoimmun Rev. 2009 ; 8: 426-430
2. Jönsen A, Bengtsson AA, Nived O, Truedsson L, Sturfelt G. Gene-environment interactions in the etiology of systemic lupus erythematosus. Autoimmunity. 2007 ; 40: 613-617
3. Amital H, Govoni M, Maya R, et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol. 2008 ; 26: S27 - S32
4. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus. 2008 ; 17: 371-375 (Pubitemid 351798710)
5. Suzuki M, Ross GF, Wiers K, et al. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol. 2007 ; 22: 2047-2057 (Pubitemid 350090711)
6. Lefranc D, Launay D, Dubucquoi S, et al. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum. 2007 ; 56: 3420-3432 (Pubitemid 47585437)
7. Huang Z, Shi Y, Cai B, et al. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus. Rheumatology (Oxford). 2009 ; 48: 626-631
8. Dai Y, Hu C, Wang L, et al. Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. Scand J Rheumatol. 2010 ; 39: 240-246
9. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999 ; 29: 1181-1189
10. Coen M, Holmes E, Lindon JC, Nicholson JK. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 2008 ; 21: 9-27 (Pubitemid 351219705)
11. Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD. Analytical and statistical approaches to metabolomics research. J Sep Sci. 2009 ; 32: 2183-2199
12. Ludwig C, Ward DG, Martin A, et al. Fast targeted multidimensional NMR metabolomics of colorectal cancer. Magn Reson Chem. 2009 ; 47: S68 - S73
13. Tiziani S, Lopes V, Günther UL. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia. 2009 ; 11: 269-276
14. Maher AD, Crockford D, Toft H, et al. Optimization of human plasma 1H NMR spectroscopic data processing for high-throughput metabolic phenotyping studies and detection of insulin resistance related to type 2 diabetes. Anal Chem. 2008 ; 80: 7354-7362
15. Sinclair AJ, Viant MR, Ball AK, et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases-a diagnostic tool?. NMR Biomed. 2010 ; 23: 123-132
16. Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002 ; 8: 1439-1444 (Pubitemid 36019430)
17. Glocker MO, Guthke R, Kekow J, Thiesen HJ. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev. 2006 ; 26: 63-87 (Pubitemid 43986470)
18. Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett. 1993 ; 8 (317). 135-138 (Pubitemid 23043956)
19. Damyanovich AZ, Staples JR, Chan AD, Marshall KW. Comparative study of normal and osteoarthritic canine synovial fluid using 500 MHz 1H magnetic resonance spectroscopy. JOrthop Res. 1999 ; 17: 223-231 (Pubitemid 29190495)
20. Meshitsuka S, Yamazaki E, Inoue M, Hagino H, Teshima R, Yamamoto K. Nuclear magnetic resonance studies of synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Clin Chim Acta. 1999 ; 281: 163-167 (Pubitemid 29142325)
21. Lamers RJ, DeGroot J, Spies-Faber EJ, et al. Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs. J Nutr. 2003 ; 133: 1776-1780 (Pubitemid 36666512)
22. Fuchs B, Schiller J, Wagner U, Häntzschel H, Arnold K. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin Biochem. 2005 ; 38: 925-933 (Pubitemid 41316652)
23. Weljie AM, Dowlatabadi R, Miller BJ, Vogel HJ, Jirik FR. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J Proteome Res. 2007 ; 6: 3456-3464 (Pubitemid 47522736)
24. Nived O, Sturfelt G. ACR classification criteria for systemic lupus erythematosus: complement components. Lupus. 2004 ; 13: 877-879 (Pubitemid 39551626)
25. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 ; 31: 315-324 (Pubitemid 18091653)
26. J Postgrad Med. 2002 ; 48: 206-208
27. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007 ; 6: 469-479 (Pubitemid 46340151)
28. Ni Y, Su M, Lin J, et al. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Lett. 2008 ; 582: 2627-2636
29. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 ; 67: 793-811
30. Martin F-PJ, Rezzi S, Montoliu I, et al. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res. 2009 ; 8: 2376-2387
31. Lin ZY, Xu PB, Yan SK, et al. A metabonomic approach to early prognostic evaluation of experimental sepsis by 1H NMR and pattern recognition. NMR Biomed. 2009 ; 22: 601-608
32. Sitton NG, Dixon JS, Bird HA, Wright V. Serum biochemistry in rheumatoid arthritis, seronegative arthropathies, osteoarthritis, SLE and normal subjects. Br J Rheumatol. 1987 ; 26: 131-135 (Pubitemid 17059489)
33. Tetlow LC, Woolley DE. Histamine stimulates the proliferation of human articular chondrocytes invitro and is expressed by chondrocytes in osteoarthritic cartilage. Ann Rheum Dis. 2003 ; 62: 991-994 (Pubitemid 37159499)
34. Watanabe M, Suliman ME, Qureshi AR, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr. 2008 ; 87: 1860-1866 (Pubitemid 351872652)
35. Kumar A, Bala L, Kalita J, et al. Metabolomic analysis of serum by 1H NMR spectroscopy in amyotrophic lateral sclerosis. Clin Chim Acta. 2010 ; 411: 563-567
36. Bongiovanni R, Yamamoto BK, Jaskiw GE. Improved method for the measurement of large neutral amino acids in biological matrices. J Chromatogr B Biomed Sci Appl. 2001 ; 754: 369-376 (Pubitemid 32261032)
37. Pawlak J, Brito V, Kuppers E, Beyer C. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res. 2005 ; 138: 1-7 (Pubitemid 41032924)
38. Poulopoulou C, Papadopoulou-Daifoti Z, Hatzimanolis A, et al. Glutamate levels and activity of the T-cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus. Arthritis Rheum. 2008 ; 58: 1445-1450 (Pubitemid 351705933)
39. De Carvalho JF, Bonfá E, Borba EF. Systemic lupus erythematosus and 'lupus dyslipoproteinemia'. Autoimmun Rev. 2008 ; 7: 246-250
40. Posadas-Romero C, Torres-Tamayo M, Zamora-González J, et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum. 2004 ; 50: 160-165 (Pubitemid 38084300)
41. Chung CP, Oeser A, Raggi P, et al. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 2010 ; 37: 1633-1638